During the past decade, HSHS Medical Group Diabetes Research conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "HSHS Medical Group Diabetes Research" #1 collaborator was "Insulet Corporation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "HSHS Medical Group Diabetes Research" are "Diabetes Mellitus, Type 2" (1 trials), "Type 2 Diabetes" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "HSHS Medical Group Diabetes Research" in a lesser frequency.

Most popular intervention types in "HSHS Medical Group Diabetes Research" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Dulaglutide" (1 trials), "Empagliflozin (oral)" (1 trials), "Glimepiride (oral)" (1 trials), "Human regular U-500 insulin (CSII)" (1 trials) and "Human regular U-500 insulin (MDI)" (1 trials). Other intervention names were less common.

The vast majority of trials in "HSHS Medical Group Diabetes Research" are 3 trials for "All" genders.

Currently, there are NaN active trials in "HSHS Medical Group Diabetes Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in HSHS Medical Group Diabetes Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in HSHS Medical Group Diabetes Research, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".